BWM
RKDA icon

BNC Wealth Management’s Arcadia Biosciences RKDA Stock Holding History

BNC Wealth Management’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-65
Closed -$7K – 384
2020
Q3 		$7K Buy
+65
New +$8.78K ﹤0.01% 343

Other funds holding RKDA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BNC Wealth Management's RKDA Position: Q4 2020 in Review

BNC Wealth Management sold out of Arcadia Biosciences (RKDA) in Q4 2020, closing a stake of 65 shares — an estimated $7K sold.

BNC Wealth Management first reported a position in RKDA in Q3 2020 and held it in 1 quarter. The position peaked at $7K in Q3 2020. 19 funds tracked by Wall St. Rank hold RKDA as of Q4 2020.

  • BNC Wealth Management reported no remaining Arcadia Biosciences position as of Q4 2020 after selling out during the quarter.
  • BNC Wealth Management sold 65 Arcadia Biosciences shares in Q4 2020, an estimated $7K.
  • BNC Wealth Management first reported a position in Arcadia Biosciences in Q3 2020 and held it in 1 quarter.
  • BNC Wealth Management's Arcadia Biosciences position peaked at $7K in Q3 2020.
  • 19 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2020.

Based on BNC Wealth Management's 13F filing for Q4 2020, filed 5 Mar 2021.